Literature DB >> 1785309

Psychological impact of significantly short stature.

P T Siegel1, R Clopper, B Stabler.   

Abstract

These baseline data confirm that many children with significantly short stature are vulnerable to diverse developmental, social and educational problems, and substantiate the importance of a multidisciplinary treatment approach that includes a comprehensive psychological and medical assessment. The psychological assessment should focus on the early detection of problems in academic achievement and psychosocial development, in order that appropriate educational and counselling interventions can be provided. The paediatrician can also foster a positive relationship with patients and their families to facilitate treatment compliance and improve overall outcome in several ways. These include a simple explanation of the aetiology of the child's short stature and how the diagnosis was made, a review of the treatment protocol that includes information about potential side-effects and suggestions for minimizing conflicts about injections, and an open discussion of prognosis to help families develop realistic expectations. It is further suggested that paediatricians stress that treatment outcome should be assessed in psychological terms, such as increased responsibility, as well as physical growth. These anticipatory interventions will help to ensure that the eventual outcome of comprehensive treatment is an optimally functioning young adult.

Entities:  

Mesh:

Year:  1991        PMID: 1785309     DOI: 10.1111/apa.1991.80.s377.14

Source DB:  PubMed          Journal:  Acta Paediatr Scand Suppl        ISSN: 0300-8843


  12 in total

1.  Psychological and emotional development, intellectual capabilities, and body image in short normal children.

Authors:  E Molinari; A Sartori; A Ceccarelli; S Marchi
Journal:  J Endocrinol Invest       Date:  2002-04       Impact factor: 4.256

2.  Behavioral evaluation of GH treatment in short statured children and adolescents: findings from a pilot study.

Authors:  H C Steinhausen; H G Dörr; Z Malin
Journal:  J Endocrinol Invest       Date:  2002-04       Impact factor: 4.256

3.  Inhibiting the integrated stress response pathway prevents aberrant chondrocyte differentiation thereby alleviating chondrodysplasia.

Authors:  Cheng Wang; Zhijia Tan; Ben Niu; Kwok Yeung Tsang; Andrew Tai; Wilson C W Chan; Rebecca L K Lo; Keith K H Leung; Nelson W F Dung; Nobuyuki Itoh; Michael Q Zhang; Danny Chan; Kathryn Song Eng Cheah
Journal:  Elife       Date:  2018-07-19       Impact factor: 8.140

4.  Quality of life in pre-adolescence: a 17-dimensional health-related measure (17D).

Authors:  M Apajasalo; J Rautonen; C Holmberg; J Sinkkonen; V Aalberg; H Pihko; M A Siimes; I Kaitila; A Mäkelä; K Erkkilä; H Sintonen
Journal:  Qual Life Res       Date:  1996-12       Impact factor: 4.147

5.  Managing idiopathic short stature: role of somatropin (rDNA origin) for injection.

Authors:  J Paul Frindik; Stephen F Kemp
Journal:  Biologics       Date:  2010-06-24

6.  The proxy problem: child report versus parent report in health-related quality of life research.

Authors:  N C Theunissen; T G Vogels; H M Koopman; G H Verrips; K A Zwinderman; S P Verloove-Vanhorick; J M Wit
Journal:  Qual Life Res       Date:  1998-07       Impact factor: 4.147

7.  Final height in children with chronic renal failure who have not received growth hormone.

Authors:  Jean-Luc André; Rosine Bourquard; Francis Guillemin; Marie-Jeanne Krier; Serge Briançon
Journal:  Pediatr Nephrol       Date:  2003-05-15       Impact factor: 3.714

Review 8.  Turner syndrome and female sex chromosome aberrations: deduction of the principal factors involved in the development of clinical features.

Authors:  T Ogata; N Matsuo
Journal:  Hum Genet       Date:  1995-06       Impact factor: 4.132

9.  Prepubertal children with short stature have a different perception of their well-being and stature than their parents.

Authors:  A Erling; I Wiklund; K Albertsson-Wikland
Journal:  Qual Life Res       Date:  1994-12       Impact factor: 4.147

10.  Effects of enzyme replacement therapy on growth in patients with mucopolysaccharidosis type II.

Authors:  G Schulze-Frenking; Simon A Jones; J Roberts; M Beck; J E Wraith
Journal:  J Inherit Metab Dis       Date:  2010-10-27       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.